Is intralesional Candida albicans antigen injection appropriate for treating common or plantar warts in children after failure of salicylic acid and cryotherapy?

Intralesional Candida Antigen for Pediatric Warts After First-Line Treatment Failure

Intralesional Candida albicans antigen injection is an appropriate and effective third-line treatment option for children with common or plantar warts that have failed salicylic acid and cryotherapy. While not included in the British Association of Dermatologists' primary recommendations, it is listed among "other treatments" for pediatric warts, and recent evidence demonstrates strong efficacy with acceptable tolerability in children 1.

Evidence Supporting Use in Children

Efficacy Data

• Complete clearance rates in children range from 47% to 87% across multiple studies, with most requiring an average of 2.7 to 3.8 treatment sessions 2, 3, 4.
• The most robust pediatric study (220 children) demonstrated 70.9% complete response and 16.8% partial response, with an average of 2.73 treatments needed 2.
• Distant wart clearance (untreated warts resolving) occurred in 21-68% of children with multiple warts, with complete distant resolution in 34-57% of these cases 2, 4.

Recent High-Quality Evidence

• A 2025 randomized phase IIa trial established optimal dosing: 0.5 mL injected into a single wart achieved 79.5% clearance of the injected wart (vs. 41.9% placebo) and significantly higher clearance of untreated warts 5.
• A 2024 systematic review and meta-analysis confirmed Candida injection demonstrated significant improvement over saline (risk ratio 5.39; 95% CI 3.49-8.33) 6.

Positioning in Treatment Algorithm

When to Consider

The British Association of Dermatologists guidelines establish the following hierarchy for pediatric hand and foot warts 1:

First-line options:

• Salicylic acid 15-40% topical preparations
• Gentle cryotherapy fortnightly for 3-4 months

Other treatments (including Candida):

• Cidofovir, formaldehyde, glutaraldehyde, laser, silver nitrate, systemic retinoids, topical immunotherapy 1

Candida antigen should be considered when:

• Standard treatments (salicylic acid and cryotherapy) have failed after 3-4 months
• Multiple or recalcitrant warts are present
• The child can tolerate intralesional injections (typically age 5 and older based on practical considerations)

Practical Implementation

Dosing Protocol

• Inject 0.3-0.5 mL into the largest wart (0.5 mL appears more effective for distant wart clearance) 5
• Repeat injections every 2 weeks until clearance or for maximum of 5-10 sessions 2, 5, 7
• If local tolerance issues develop, extend interval to every 3 weeks 5

Safety Profile

• All patients experience discomfort during injection, but no serious adverse effects have been reported in pediatric studies 2, 3, 4
• Adverse effects are generally mild and manageable 6
• This contrasts favorably with the guideline's emphasis that "painful treatments are often not tolerated and should be avoided in young children if possible" 1

Important Caveats

Guideline Context

The British Association of Dermatologists guidelines note that "warts in children are often relatively short lived and are likely to clear within a year or two" 1. This suggests watchful waiting remains reasonable for non-painful, non-functional warts.

Comparative Effectiveness

• Candida antigen is superior to PPD for plantar warts (82.5% vs. 55.6% complete clearance) 7
• No significant difference exists between Candida and other intralesional immunotherapies (mumps-measles-rubella vaccine, vitamin D3, zinc sulfate) 6
• The 2024 meta-analysis found Candida superior to saline but comparable to other active immunotherapies 6

Limitations

• Not FDA-approved specifically for wart treatment (off-label use)
• Requires intralesional injection skill and patient cooperation
• The British Association of Dermatologists guidelines list it as "insufficient evidence" in their summary table, though this reflects the 2014 publication date before recent high-quality studies 1

Clinical Decision Points

Choose Candida antigen when:

• Multiple warts are present (to exploit distant clearance effect)
• Child is old enough to tolerate injections with local anesthesia
• Plantar location with functional impairment
• Parents/patients prefer fewer office visits than ongoing cryotherapy

Consider alternative approaches when:

• Single small wart in young child (continue conservative management)
• Severe needle phobia
• Immunosuppressed patients (though limited data suggests possible efficacy) 8